In the present study, we observed that atrazine exerted estrogen-like activity in ovarian and breast cancer cells and in CAFs through GPER, which mediated estrogen signals, as reported in previous studies (reviewed by Prossnitz and Barton 2014). The gene discussed is GPER1; the disease is breast carcinoma.